Acetylome regulation by sirtuins in the brain: From normal physiology to aging and pathology

Current Pharmaceutical Design

Volumn 19, Issue 38, 2013, Pages 6823-6838

  Michan, Shaday ^a  

^a INSTITUTO NACIONAL DE GERIATRÍA   (Mexico)

Author keywords

Acetylome; Aging; Brain; Calorie restriction; Lysine acetyltransferases; Lysine deace tylases; Neurodegeneration; Reversible lysine acetylation; SIRT1; Sirtuins

Indexed keywords

NONHISTONE PROTEIN; SIRTUIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LYSINE; PROTEOME;

ACETYLATION; AGING; APOPTOSIS; ARTICLE; AUTOPHAGY; BRAIN FUNCTION; CALORIC RESTRICTION; CIRCADIAN RHYTHM; COGNITION; DNA TRANSCRIPTION; ENERGY BALANCE; FUNCTIONAL GENOMICS; MACHINE; NERVE DEGENERATION; NERVOUS SYSTEM DEVELOPMENT; NEUROPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SYNAPSE; ANIMAL; BRAIN; BRAIN TUMOR; CELL AGING; DEGENERATIVE DISEASE; DNA DAMAGE; EMOTION; HUMAN; METABOLISM; OXIDATIVE STRESS; PATHOLOGY; PHYSIOLOGY; REVIEW;

ACETYLATION; AGING; ANIMALS; AUTOPHAGY; BRAIN; BRAIN NEOPLASMS; CELL AGING; CIRCADIAN RHYTHM; DNA DAMAGE; EMOTIONS; HUMANS; LYSINE; NEURODEGENERATIVE DISEASES; NEUROGENESIS; NF-KAPPA B; OXIDATIVE STRESS; PROTEOME; SIRTUINS;

EID: 84881537665     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/1381612811319380014     Document Type: Article

References (178)

1. [1] Boeckmann B, Blatter MC, Famiglietti L, et al. Protein variety and functional diversity: Swiss-Prot annotation in its biological context. C R Biol 2005; 328: 882-99.
2. [2] Kamath KS, Vasavada MS, Srivastava S. Proteomic databases and tools to decipher post-translational modifications. J Proteomics 2011; 75: 127-44.
3. [3] Witze ES, Old WM, Resing KA and Ahn NG. Mapping protein post-translational modifications with mass spectrometry. Nat Meth 2007; 4: 798-806.
4. [4] Starheim, KK, Gevaert K and Arnesen T. Protein N-terminal ace- tyltransferases: when the start matters. Trends Biochem Sci 2012; 37: 152-61.
5. [5] Phillips D, The presence of acetyl groups of histones. Biochem J 1963; 87: 258-63.
6. [6] Allfrey VG, Faulkner R and Mirsky A. Acetylation and methyla- tion of histones and their possible role in the regulation of RNA synthesis. Proc Natl Acad Sci USA 1964; 51: 786-94.
7. [7] Mueller R, Yasuda H, Hatch C, et al. Identification of ubiquitinated histones 2A and 2B in Physarum polycephalum. Disappearance of these proteins at metaphase and reappearance at anaphase. J Biol Chem 1985; 260: 5147-53.
8. [8] Langan T. Action of adenosine 3’,5'-monophosphate-dependent histone kinase in vivo. J Biol Chem 1969; 244: 5763-65.
9. [9] Liokatis S, Stützer A, Elsässer SJ, et al. Phosphorylation of histone H3 Ser10 establishes a hierarchy for subsequent intramolecular modification events. Nat Struct Mol Biol 2012; 19: 819-23.
10. [10] DeLange R.and Smith E., Histones: structure and function. Annu Rev Biochem 1971; 40: 279-314.
11. [11] Rickwood D, MacGillivray A and Whish W. The modification of nuclear proteins by ADP-ribosylation. Eur J Biochem 1977; 79: 589-98.
12. [12] Shiio Y, Eisenman RN. Histone sumoylation is associated with transcriptional repression. Proc Natl Acad Sci USA 2003; 100: 13225-30.
13. [13] Hagiwara T, Nakashima K, Hirano H, et al. Deimination of argin-ine residues in nucleophosmin/B23 and histones in HL-60 granulo-cytes. Biochem Biophys Res Commun 2002; 290: 979-83.
14. [14] Cuthbert GL, Daujat S, Snowden A.W, et al. Histone deimination antagonizes arginine methylation. Cell 2004; 118: 545-53.
15. [15] Sakabe K, Wang Z and Hart GW. Beta-N-acetylglucosamine (O-GlcNAc) is part of the histone code. Proc Natl Acad Sci USA 2010; 107 19915-20.
16. [16] Wang Z, Zang C, Cui K, Schones DE, et al. Genome-wide mapping of HATs and HDACs reveals distinct functions in active and inactive genes. Cell 2009; 138: 1019-31.
17. [17] Sterner R, Vidali G and Allfrey VG. Studies of acetylation and deacetylation in high mobility group proteins. Identification of the sites of acetylation in HMG-1. J Biol Chem 1979; 254: 11577-83.
18. [18] Choudhary C, Kumar C, Gna F, et al. Lysine Acetylation Targets Protein Complexes and Co-Regulates Major Cellular Functions. Science 2009; 325: 834-40.
19. [19] Lu Z, Cheng Z, Zhao Y, Volchenboum SL. Bioinformatic analysis and post-translational modification crosstalk prediction of lysine acetylation. PloS one 2011; 6: e28228.
20. [20] Kaluarachchi Duffy S, Friesen H, Baryshnikova A, et al. Exploring the yeast acetylome using functional genomics. Cell 2012; 149: 936-48.
21. [21] Liu Z, Cao J, Gao X, et al. CPLA 1.0: an integrated database of protein lysine acetylation. Nucleic Acids Res 2011; 39: D1029-34.
22. [22] Kim GW, Yang XJ, Comprehensive lysine acetylomes emerging from bacteria to humans. Trends Biochemical Sci 2010; 36: 211-20.
23. [23] Weinert BT, Wagner SA, Horn H, et al. Proteome-Wide Mapping of the Drosophila Acetylome Demonstrates a High Degree of Conservation of Lysine Acetylation. Sci Signa. 2011; 4: 1-11.
24. [24] Wu X, Oh MH, Schwarz EM, et al. Lysine Acetylation Is a Widespread Protein Modification for Diverse Proteins in Arabidopsis. Plant Physiol 2011; 155: 1769-78.
25. [25] Lin YY, Lu JY, Zhang J, et al. Protein acetylation microarray reveals that NuA4 controls key metabolic target regulating glu-coneogenesis. Cell 2009; 136: 1073-84.
26. [26] Chen Y, Zhao W, Yang JSS, et al. Quantitative Acetylome Analysis Reveals the Roles of SIRT1 in Regulating Diverse Substrates and Cellular Pathways. Mol Cell Proteomics P 2012; 11: 1048-62.
27. [27] Zhao S, Xu W, Jiang W, et al. Regulation of cellular metabolism by protein lysine acetylation. Science 2010; 327: 1000-4.
28. [28] Kim SC, Sprung R, Chen Y, et al. Substrate and Functional Diversity of Lysine Acetylation Revealed by a Proteomics Survey. Mol Cell 2006; 23: 607-18.
29. [29] Kendrick AA, Choudhury M, Rahman SMM, et al. Fatty liver is associated with reduced SIRT3 activity and mitochondrial protein hyperacetylation. J Biol Chem 201; 433: 505-14.
30. [30] Schwer B, Eckersdorff M, Li Y, et al. Calorie restriction alters mitochondrial protein acetylation. Aging Cell 2009; 8: 604-6.
31. [31] Yang L, Vaitheesvaran B, Hartil K, et al. The fasted/fed mouse metabolic acetylome: N6-acetylation differences suggest acetyla-tion coordinates organ-specific fuel switching. J Proteome Res 2011; 10: 4134-49.
32. [32] Vaitheesvaran B, Yang L, Hartil K, et al. Peripheral effects of FAAH deficiency on fuel and energy homeostasis: role of dysregu-lated lysine acetylation. PloS one 2012; 7: e33717.
33. [33] Taunton J, Hassig C, Schreiber S. A mammalian histone deacety-lase related to the yeast transcriptional regulator Rpd3p. Science 1996; 272: 408-11.
34. [34] Brownell JE, Zhou J, Ranalli T, et al. Tetrahymena Histone Acetyl-transferase A: A Homolog to Yeast Gcn5p Linking Histone Acety-lation to Gene Activation. Cell 1996; 84: 843-51.
35. [35] Imai S, Armstrong CM, Kaeberlein M and Guarente L. Transcrip-tional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase. Nature 2000; 403: 795-800.
36. [36] Spange S, Wagner T, Heinzel T, Krämer OH. Acetylation of non-histone proteins modulates cellular signalling at multiple levels. Int J Biochem Cell Biol 2009; 41: 185-98.
37. [37] Gregoretti IV, Lee YMM, Goodson HV, Molecular evolution of the histone deacetylase family: functional implications of phylogenetic analysis. J Mol Biol 2004; 338: 17-31.
38. [38] Yang X and Seto E. HATs and HDACs: from structure, function and regulation to novel strategies for therapy and prevention. On-cogene 2007; 26: 5310-8.
39. [39] Roth SY, Denu JM and Allis CD. Histone acetyltransferases. Annu Rev Biochem 2001; 70: 81-120.
40. [40] Ogryzko VV. Mammalian histone acetyltransferases and their complexes. Cell Mol Life Sci 2001; 58: 683-92.
41. [41] Witt O, Deubzer HE, Milde T and Oehme I. HDAC family: What are the cancer relevant targets? Cancer Lett 2009; 277: 8-21.
42. [42] Frye R. Phylogenetic classification of prokaryotic and eukaryotic Sir2-like proteins. Biochem Biophys Res Commun 2000; 273: 793-8.
43. [43] Michan S and Sinclair D. Sirtuins in mammals: insights into their biological function. J Biol Chem 2007; 404: 1-13.
44. [44] Lee IH, Cao L, Mostoslavsky R, et al. A role for the NAD-dependent deacetylase Sirt1 in the regulation of autophagy. Proc Natl Acad Sci USA 2008; 105: 3374-9.
45. [45] Finnin MS, Donigian JR and Pavletich NP. Structure of the histone deacetylase SIRT2. Nat Struct Mol Biol 2001; 8: 621-5.
46. [46] Lombard DB, Alt FW, Cheng HL, et al. Mammalian Sir2 Homolog SIRT3 Regulates Global Mitochondrial Lysine Acetylation. Mol Cell Biol 2007; 27: 8807-14.
47. [47] Michan S and Sinclair D. Sirtuins in mammals: insights into their biological function. J Biol Chem 2007; 404: 1-13.
48. [48] Tanno M, Sakamoto J, Miura T, et al. Nucleocytoplasmic shuttling of the NAD+-dependent histone deacetylase SIRT1. J Biol Chem 2007, 282, 6823-32.
49. [49] North BJ and Verdin E. Mitotic regulation of SIRT2 by cyclin-dependent kinase 1-dependent phosphorylation. J Biol Chem 2007; 282: 19546-55.
50. [50] Wang F and Tong Q. SIRT2 suppresses adipocyte differentiation by deacetylating FOXO1 and enhancing FOXO1’s repressive interaction with PPARy. Mol Biol Cell 2009; 20: 801-8.
51. [51] North BJ, Marshall BL, Borra MT, et al. The human Sir2 ortholog, SIRT2, is an NAD+-dependent tubulin deacetylase. Mol Cell 2003; 1: 437-44.
52. [52] Wang F, Nguyen M, Qin FX and Tong Q. SIRT2 deacetylates FOXO3a in response to oxidative stress and caloric restriction. Aging Cell 2007; 6: 505-14.
53. [53] Rothgiesser KM, Erener S, Waibel S, et al. SIRT2 regulates NF-KB-dependent gene expression through deacetylation of p65 Lys310. J Cell Sci 2010; 123: 4251-8.
54. [54] Kim HSS, Vassilopoulos A, Wang RHH, Lahusen T, et al. SIRT2 maintains genome integrity and suppresses tumorigenesis through regulating APC/C activity. Cancer Cell 2011; 20: 487-99.
55. [55] Ishfaq M, Maeta K, Maeda S, et al. Acetylation regulates subcellular localization of eukaryotic translation initiation factor 5A (eIF5A). FEBS Letters 2012; 586: 3236-41.
56. [56] Palacios OM, Carmona JJ, Michan S, et al. Diet and exercise signals regulate SIRT3 and activate AMPK and PGC-1alpha in skeletal muscle. Aging 2009; 1: 771-83.
57. [57] Hirschey MD, Shimazu T, Goetzman E, et al. SIRT3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylation. Nature 2010; 464: 121-5.
58. [58] Kim HSS, Patel K, Muldoon-Jacobs K, et al. SIRT3 is a mitochondria-localized tumor suppressor required for maintenance of mitochondrial integrity and metabolism during stress. Cancer Cell 2010; 17: 41-52.
59. [59] Finley LW, Carracedo A, Lee, et al. SIRT3 opposes reprogram-ming of cancer cell metabolism through HIF1a destabilization. Cancer Cell 2011; 19: 416-28.
60. [60] Hafner AV, Dai J, Gomes AP, et al. Regulation of the mPTP by SIRT3-mediated deacetylation of CypD at lysine 166 suppresses age-related cardiac hypertrophy. Aging 2010; 2: 914-23.
61. [61] Pillai VB, Sundaresan NR, Kim G, Gupta M, et al. Exogenous NAD blocks cardiac hypertrophic response via activation of the SIRT3-LKB1-AMP-activated kinase pathway. J Biol Chem 2010; 285: 3133-44.
62. [62] Sundaresan NR, Gupta M, Kim G, Rajamohan SB, et al. Sirt3 blocks the cardiac hypertrophic response by augmenting Foxo3a-dependent antioxidant defense mechanisms in mice. J Clin Invest 2009; 119: 2758-71.
63. [63] Haigis MC, Mostoslavsky R, Haigis KM, et al. SIRT4 Inhibits Glutamate Dehydrogenase and Opposes the Effects of Calorie Restriction in Pancreatic p Cells. Cell 2006; 126: 941-54.
64. [64] Ahuja N, Schwer B, Carobbio S, Waltregny D, et al. Regulation of insulin secretion by SIRT4, a mitochondrial ADP-ribosyltransferase. J Biol Chem 2007; 282: 33583-92.
65. [65] Du J, Zhou Y, Su X, et al. Sirt5 is a NAD-dependent protein lysine demalonylase and desuccinylase. Science 2011; 334: 806-9.
66. [66] Nakagawa T, Lomb DJ, Haigis MC and Guarente L. SIRT5 Deacetylates carbamoyl phosphate synthetase 1 and regulates the urea cycle. Cell 2009; 137: 560-70.
67. [67] Zhong L, D’Urso A, Toiber D, et al. The histone deacetylase Sirt6 regulates glucose homeostasis via Hif1alpha. Cell 2010; 140: 280-93.
68. [68] Sundaresan NR, Vasudevan P, Zhong L, et al. The sirtuin SIRT6 blocks IGF-Akt signaling and development of cardiac hypertrophy by targeting c-Jun. Nat Med 2012; 18: 1643-50.
69. [69] Xiao C, Wang RHH, Lahusen TJ, Park O, et al. Progression of Chronic Liver Inflammation and Fibrosis Driven by Activation of c-JUN Signaling in Sirt6 Mutant Mice. J Biol Chem 2012; 287: 41903-13.
70. [70] Kanfi Y, Naiman S, Amir G, et al. The sirtuin SIRT6 regulates lifespan in male mice. Nature 2012; 483: 218-21.
71. [71] Liszt G, Ford E, Kurtev M and Guarente L. Mouse Sir2 homo log SIRT6 is a nuclear ADP-ribosyltransferase. The J Biol Chem 2005; 280: 21313-20.
72. [72] Barber MF, Michishita-Kioi E, Xi Y, et al. SIRT7 links H3K18 deacetylation to maintenance of oncogenic transformation. Nature 2012; 487: 114-8.
73. [73] Vakhrusheva O, Smolka C, Gajawada P, et al. Sirt7 Increases Stress Resistance of Cardiomyocytes and Prevents Apoptosis and Inflammatory Cardiomyopathy in Mice. Circ Res 2008; 102: 703-10.
74. [74] Sharma SK. Protein acetylation in synaptic plasticity and memory. Neurosci Biobehav Rev 2010; 34: 1234-40.
75. [75] Fischer A, Sananbenesi F, Wang X, et al. Recovery of learning and memory is associated with chromatin remodelling. Nature 2007; 447: 178-82.
76. [76] Guan JS, Haggarty SJ, Giacometti E, et al. HDAC2 negatively regulates memory formation and synaptic plasticity. Nature 2009; 459: 55-60.
77. [77] Michan S, Li Y, Chou MMH, et al. SIRT1 is essential for normal cognitive function and synaptic plasticity. J Neurosci 2010; 30: 9695-707.
78. [78] Gao J, Wang WY, Mao YW, et al. A novel pathway regulates memory and plasticity via SIRT1 and miR-134. Nature 2010; 466: 1105-9.
79. [79] Niblock MM, Brunso-Bechtold JK and Riddle DR. Insulin-Like Growth Factor I Stimulates Dendritic Growth in Primary Somatosensory Cortex. J Neurosci 2000; 20: 4165-76.
80. [80] Gorski JA, Zeiler SR, Tamowski S and Jones KR. Brain-derived neurotrophic factor is required for the maintenance of cortical dendrites. J Neurosci 2003; 23: 6856-65.
81. [81] Zhou Z, Hong EJ, Cohen S, et al. Brain-Specific Phosphorylation of MeCP2 Regulates Activity-Dependent Bdnf Transcription, Dendritic Growth, and Spine Maturation. Neuron 2006; 52: 255-69.
82. [82] Suh Y, Atzmon G, Cho MOO, et al. Functionally significant insulin-like growth factor I receptor mutations in centenarians. Proc Natl Acad Sci USA 2008; 105: 3438-42.
83. [83] Wolkow C, Kimura K, Lee M and Ruvkun G. Regulation of C. elegans life-span by insulinlike signaling in the nervous system. Science 2000; 290: 147-50.
84. [84] Trejo JL, Piriz J, Llorens-Martin MV, et al. Central actions of liver-derived insulin-like growth factor I underlying its pro-cognitive effects. Mol Psychiatry 2007; 12: 118-28.
85. [85] Selcher JC, Atkins CM, Trzaskos JM, et al. A necessity for MAP kinase activation in mammalian spatial learning. Learn Mem 1999; 6: 478-90.
86. [86] Trifilieff P, Calandreau L, Herry C, Mons N and Micheau J. Bipha-sic ERK1/2 activation in both the hippocampus and amygdala may reveal a system consolidation of contextual fear memory 2007; 88: 424-34.
87. [87] Cohen E, Paulsson JF, Blinder P, et al. Reduced IGF-1 Signaling Delays Age-Associated Proteotoxicity in Mice. Cell 2009; 139: 1157-69.
88. [88] Li Y, Xu, Mcburney M and Longo V. SirT1 Inhibition Reduces IGF-I/IRS-2/Ras/ERK1/2 Signaling and Protects Neurons. Cell Metab 2008; 8: 38-48.
89. [89] Zeng Y, Tan M, Kohyama J, et al. Epigenetic enhancement of BDNF signaling rescues synaptic plasticity in aging. J Neurosci 2011; 31: 17800-10.
90. [90] Zocchi L and Sassone-Corsi P. SIRT1-mediated deacetylation of MeCP2 contributes to BDNF expression. Epigenetics 2012; 7: 695-700.
91. [91] Buerki C, Rothgiesser KM, Valovka T, et al. Functional relevance of novel p300-mediated lysine 314 and 315 acetylation of RelA/p65. Nucleic Acids Research 2008; 36: 1665-80.
92. [92] Kawahara TL, Michishita E, Adler AS, et al. SIRT6 links histone H3 lysine 9 deacetylation to NF-kappaB-dependent gene expression and organismal life span. Cell 2009; 136: 62-74.
93. [93] Meffert MK. Chang JM, Wiltgen BJ, et al.NF-kappa B functions in synaptic signaling and behavior. Nat Neurosci 2003; 6: 1072-8.
94. [94] Oikawa K, Odero GL, Platt E, et al. NF-kB p50 subunit knockout impairs late LTP and alters long term memory in the mouse hippocampus. BMC Neurosci 2012; 13: 45.
95. [95] Zhang X, Yuan Z, Zhang Y, et al. HDAC6 modulates cell motility by altering the acetylation level of cortactin. Mol Cell 2007; 27: 197-213.
96. [96] Zhang Y, Zhang M, Dong H, et al. Deacetylation of cortactin by SIRT1 promotes cell migration. Oncogene 2009; 28: 445-60.
97. [97] Catarino T, Ribeiro L, Santos SD and Carvalho AL. Regulation of Synapse Composition by Protein Acetylation: The Role of Acety-lated Cortactin. J Cell Sci 2012; ahead of print.
98. [98] Lopez-Atalaya JP, Ciccarelli A, Viosca J, et al. CBP is required for environmental enrichment-induced neurogenesis and cognitive enhancement. EMBO J 2011; 30: 4287-98.
99. [99] Ichia S, Boshnjakua V, Shena YW, et al. Role of Pax3 acetylation in the regulation of Hes1 and Neurog2. Mol Biol Cell 2011; 22: 503-12.
100. [100] Tiberi L, Ameele J, Dimidschstein J, et al. BCL6 controls neuro-genesis through Sirt1-dependent epigenetic repression of selective Notch targets. Nat Neurosci 2012; 15: 1627-35.
101. [101] Schwer B, Schumacher B, Lombard DB, Xiao C, et al. Neural sirtuin 6 (Sirt6) ablation attenuates somatic growth and causes obesity. PNAS 2010; 107: 21790-4.
102. [102] Satoh A, Brace CS, Ben-Josef G, et al. SIRT1 promotes the central adaptive response to diet restriction through activation of the dor-somedial and lateral nuclei of the hypothalamus. J Neurosci 2010; 30: 10220-32.
103. [103] Cakir I, Perello M, Lansari O, et al. Hypothalamic Sirt1 regulates food intake in a rodent model system. PLoS One 2009; 15: e8322.
104. [104] Ramadori G, Fujikawa T, Anderson J, et al. SIRT1 deacetylase in SF1 neurons protects against metabolic imbalance. Cell Metab 2011; 14: 301-12.
105. [105] Hasegawa K, Kawahara T, Fujiwara K, et al. Necdin Controls Foxo1 Acetylation in Hypothalamic Arcuate Neurons to Modulate the Thyroid Axis. J Neurosci 2012; 32: 5562-72.
106. [106] Naruse Y, Oh-hashi K, Iijima N, et al. Circadian and light-induced transcription of clock gene Per1 depends on histone acetylation and deacetylation. Mol Cell Biol 2004; 24: 6278-87.
107. [107] Belden WJ and Dunlap JC SIRT1 is a circadian deacetylase for core clock components. Cell 2008; 134: 212-4.
108. [108] Hirayama J, Sahar S, Grimaldi B, et al. CLOCK-mediated acetyla-tion of BMAL1 controls circadian function. Nature 2007; 450: 1086-90.
109. [109] Nakahata Y, Kaluzova M, Grimaldi B, et al. The NAD+-Dependent Deacetylase SIRT1 Modulates CLOCK-Mediated Chromatin Remodeling and Circadian Control. Cell 2008; 134: 329-40.
110. [110] Asher G, Gatfield D, Stratmann M, et al. SIRT1 regulates circadian clock gene expression through PER2 deacetylation. Cell 2008; 134: 317-28.
111. [111] Grimaldi B, Nakahata Y, Sahar S, et al. Chromatin remodeling and circadian control: master regulator CLOCK is an enzyme. Cold Spring Harb Symp Quant Biol 2007; 72: 105-12.
112. [112] Miki T, Xu Z, Chen-Goodspeed M, et al. PML regulates PER2 nuclear localization and circadian function. EMBO J 2012; 31: 1427-39.
113. [113] Soldán MPM and Pirko I. Biogenesis and significance of central nervous system myelin. Semin Neurol 2012; 32: 9-14.
114. [114] Roth AD, Ivanova A and Colman DR. New observations on the compact myelin proteome. Neuron Glia Biology 2006; 2: 15-21.
115. [115] Li W, Zhang B, Tang J, et al. Sirtuin 2, a mammalian homolog of yeast silent information regulator-2 longevity regulator, is an oli-godendroglial protein that decelerates cell differentiation through deacetylating alpha-tubulin. J Neurosci 2007; 27: 2606-16.
116. [116] Beirowski B, Gustin J, Armour SM, et al. Sir-two-homolog 2 (Sirt2) modulates peripheral myelination through polarity protein Par-3/atypical protein kinase C (aPKC) signaling. Proc Natl Acad Sci USA 2011; 108: E952-61.
117. [117] Collier TJ and Coleman PD. Divergence of biological and chronological aging: Evidence from rodent studies. Neurobiol Aging 1991; 12: 685-93.
118. [118] Peleg S, Sananbenesi F, Zovoilis A, et al. Altered Histone Acetyla-tion Is Associated with Age-Dependent Memory Impairment in Mice. Science 2010; 328: 753-6.
119. [119] Lu T, Pan Y, Kao SYY, et al. Gene regulation and DNA damage in the ageing human brain. Nature 2004; 429: 883-91.
120. [120] Sinclair DA and Oberdoerffer P. The ageing epigenome: Damaged beyond repair? Ageing Res Rev 2009; 8: 189-98.
121. [121] Oberdoerffer P, Michan S, McVay M, et al. SIRT1 Redistribution on Chromatin Promotes Genomic Stability but Alters Gene Expression during Aging. Cell 2008; 135: 907-18.
122. [122] Fan W and Luo J. SIRT1 Regulates UV-Induced DNA Repair through Deacetylating XPA. Mol Cell 2010; 39: 247-58.
123. [123] Jaarsma D, van der Pluijm I, de Waard MC, et al. Age-Related Neuronal Degeneration: Complementary Roles of Nucleotide Excision Repair and Transcription-Coupled Repair in Preventing Neuropathology. PLoS Genet 2011; 7: e1002405.
124. [124] Cohen HY, Miller C, Bitterman KJ, et al. Calorie Restriction Promotes Mammalian Cell Survival by Inducing the SIRT1 Deacety-lase. Science 2004; 305: 390-2.
125. [125] Jurk D, Wang C, Miwa S, et al. Postmitotic neurons develop a p21-dependent senescence-like phenotype driven by a DNA damage response. Aging Cell 2012; 11: 996-1004.
126. [126] Pallas M, Pizarro JG, Gutierrez-Cuesta J, et al. Modulation of SIRT1 expression in different neurodegenerative models and human pathologies. Neuroscience 2008; 154: 1388-97.
127. [127] Panossian L, Fenik P, Zhu Y, et al. SIRT1 regulation of wakefulness and senescence-like phenotype in wake neurons. J Neurosci 2011; 31: 4025-36.
128. [128] Mao Z, Tian X, Van Meter M, et al. Sirtuin 6 (SIRT6) rescues the decline of homologous recombination repair during replicative senescence. Proc Natl Acad Sci USA 2012; 109: 11800-5.
129. [129] Kaidi A, Weinert BT, Choudhary C and Jackson SP. Human SIRT6 promotes DNA end resection through CtIP deacetylation. Science 2010; 329: 1348-53.
130. [130] Robert T, Vanoli F, Chiolo I et al. HDACs link the DNA damage response, processing of double-strand breaks and autophagy. Nature 2011; 471: 74-9.
131. [131] Alirezaei M, Kemball CC, Flynn CT, et al. Short-term fasting induces profound neuronal autophagy. Autophagy 2010; 6: 702-10.
132. [132] Lee IH, Cao L, Mostoslavsky R, et al. A role for the NAD-dependent deacetylase Sirt1 in the regulation of autophagy. Proc Natl Acad Sci USA 2008; 105: 3374-3379.
133. [133] Mariño G, Morselli E, Bennetzen MV, et al. Longevity-relevant regulation of autophagy at the level of the acetylproteome. Autophagy 2011; 7: 647-9.
134. [134] Ristow M and Zarse K. How increased oxidative stress promotes longevity and metabolic health: The concept of mitochondrial hor-mesis (mitohormesis). Exp Gerontol 2010; 45: 410-8.
135. [135] Tao R, Coleman MC, Pennington DD, et al. Sirt3-mediated deacetylation of evolutionarily conserved lysine 122 regulates MnSOD activity in response to stress. Mol Cell 2010; 40: 893-904.
136. [136] Someya S, Yu W, Hallows WC, et al. Sirt3 mediates reduction of oxidative damage and prevention of age-related hearing loss under caloric restriction. Cell 2010; 143: 802-12.
137. [137] Nemoto S, Fergusson MM, Finkel T. SIRT1 functionally interacts with the metabolic regulator and transcriptional coactivator PGC-1a. J Biol Chem 2005; 280: 16456-60.
138. [138] Cheng HLL, Mostoslavsky R, Saito S, et al. Developmental defects and p53 hyperacetylation in Sir2 homolog (SIRT1)-deficient mice. Proc Natl Acad Sci USA 2003; 100: 10794-9.
139. [139] Lim JHH, Lee YMM, Chun YSS, et al. Sirtuin 1 modulates cellular responses to hypoxia by deacetylating hypoxia-inducible factor 1alpha. Molecular Cell 2010; 38: 864-78.
140. [140] Bell E, Emerling B, Ricoult S, Guarente L. SirT3 suppresses hypoxia inducible factor 1a and tumor growth by inhibiting mitochondrial ROS production. Oncogene 2011; 30: 2986-96.
141. [141] Prozorovski T, Schulze-Topphoff U, Glumm R, et al. Sirt1 contributes critically to the redox-dependent fate of neural progenitors Nat Cell Biol 2008; 10: 385-394.
142. [142] Hovatta I and Barlow C. Molecular genetics of anxiety in mice and men. Ann Med 2008; 40: 92-109.
143. [143] Fukada M, Hanai A, Nakayama A, et al. Loss of deacetylation activity of Hdac6 affects emotional behavior in mice. PloS one 2012; 7: e30924.
144. [144] Libert S, Pointer K, Bell EL, et al. SIRT1 activates MAO-A in the brain to mediate anxiety and exploratory drive. Cell 2011; 147: 1459-72.
145. [145] Kishi T, Yoshimura R, Kitajima T, et al. SIRT1 gene is associated with major depressive disorder in the Japanese population. J Affect Disorders 2010; 126: 167-73.
146. [146] Sebastián C, Zwaans BMM, Silberman DM, et al. The Histone Deacetylase SIRT6 Is a Tumor Suppressor that Controls Cancer Metabolism. Cell 2012; 151: 1185-99.
147. [147] Kim HSS, Patel K, Muldoon-Jacobs K, et al. SIRT3 is a mitochondria-localized tumor suppressor required for maintenance of mitochondrial integrity and metabolism during stress. Cancer Cell 2010; 17: 41-52.
148. [148] Firestein R, Blander G, Michan S, et al. The SIRT1 deacetylase suppresses intestinal tumorigenesis and colon cancer growth. PloS one 2008; 3: e2020.
149. [149] Hiratsukaa M, Inoueb T, Todac T, et al. Proteomics-based identification of differentially expressed genes in human gliomas: down-regulation of SIRT2 gene. Biochem Biophys Res Commun 2003; 309: 558-66.
150. [150] Dixit D, Sharma V, Ghosh S, Mehta VS, Sen E. Inhibition of Casein kinase-2 induces p53-dependent cell cycle arrest and sensitizes glioblastoma cells to tumor necrosis factor (TNFa)-induced apop-tosis through SIRT1 inhibition. Cell Death Dis 2012; 3: e271
151. [151] Selkoe D. Alzheimer’s disease: genes, proteins, and therapy. Physiol Rev 2001; 81: 741-66.
152. [152] Ko MHH and Puglielli L Two endoplasmic reticulum (ER)/ER Golgi intermediate compartment-based lysine acetyltransferases post-translationally regulate BACE1 levels. J Biol Chem 2009; 284: 2482-92.
153. [153] Donmez G, Wang D, Cohen DE and Guarente L. SIRT1 suppresses beta-amyloid production by activating the alpha-secretase gene ADAM10. Cell 2010; 142: 320-32.
154. [154] Chami L, Buggia-Prévot V, Duplan E, et al. Nuclear factor-KB regulates |3APP and |3- and y-secretases differently at physiological and supraphysiological A3 concentrations. J Biol Chem 2012; 287: 24573-84.
155. [155] Chen J, Zhou Y, Mueller-Steiner S, et al. SIRT1 protects against microglia-dependent amyloid-beta toxicity through inhibiting NF-kappaB signaling. J Biol Chem 2005; 280: 40364-74.
156. [156] Cohen TJ, Guo JL, Hurtado DE, et al. The acetylation of tau inhibits its function and promotes pathological tau aggregation. Nat Commun 2011; 2: 252.
157. [157] Irwin DJ, Cohen TJ, Grossman M, et al. Acetylated tau, a novel pathological signature in Alzheimer’s disease and other tauopathies. Brain 2012; 135: 807-18.
158. [158] Li X, Zhang S, Blander G, et al. SIRT1 deacetylates and positively regulates the nuclear receptor LXR. Mol Cell 2007; 28: 91-106.
159. [159] Jiang Q, Lee DY, Mandrekar, S, et al. ApoE promotes the proteolytic degradation of Abeta. Neuron 2008; 58: 681-93.
160. [160] Kim D, Nguyen MD, Dobbin MM, et al. SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer’s disease and amyotrophic lateral sclerosis. EMBO J 2007; 26: 3169-79.
161. [161] Jadiya P, Chatterjee M, Sammi SRR, et al. Sir-2.1 modulates “calorie-restriction-mediated” prevention of neurodegeneration in Caenorhabditis elegans: implications for Parkinson’s disease. Biochem Biophys Res Commun 2011; 413: 306-10.
162. [162] van Ham TJ, Thijssen KL, Breitling R, et al. C. elegans Model Identifies Genetic Modifiers of a-Synuclein Inclusion Formation During Aging. PLoS Genet 2008; 4: e1000027.
163. [163] Donmez G, Arun A, Chung CY, et al. SIRT1 Protects against a-Synuclein Aggregation by Activating Molecular Chaperones. J Neurosci 2012; 32: 124-32.
164. [164] Westerheide SD, Anckar J, Stevens SM, et al. Stress-inducible regulation of heat shock factor 1 by the deacetylase SIRT1. Science 2009; 323: 1063-6.
165. [165] Zhang A, Wang H, Qin X, et al. Genetic analysis of SIRT1 gene promoter in sporadic Parkinson’s disease. Biochem Biophys Res Commun 2012; 422: 693-6.
166. [166] Maxwell MM, Tomkinson EM, Nobles J, et al. The Sirtuin 2 microtubule deacetylase is an abundant neuronal protein that accumulates in the aging CNS. Hum Mol Genet 2011; 20: 3986-96.
167. [167] Outeiro TF, Kontopoulos E, Altmann SM, et al. Sirtuin 2 Inhibitors Rescue a-Synuclein-Mediated Toxicity in Models of Parkinson’s Disease. Science 2007; 317: 516-9.
168. [168] Bobrowska A, Donmez G, Weiss A, et al. SIRT2 Ablation Has No Effect on Tubulin Acetylation in Brain, Cholesterol Biosynthesis or the Progression of Huntington’s Disease Phenotypes In vivo. PLoS ONE 2012; 7: e34805.
169. [169] Liu L, Arun A, Ellis L, et al. Sirtuin 2 (SIRT2) Enhances 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced Nigrostriatal Damage via Deacetylating Forkhead Box O3a (Foxo3a) and Activating Bim Protein. J Biol Chem 2012; 287: 32307-11.
170. [170] Steffan J, Bodai L, Pallos J, et al. Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila. Nature 2001; 413: 739-43.
171. [171] Jeong H, Then F, Melia TJ, et al. Acetylation Targets Mutant Hunt-ingtin to Autophagosomes for Degradation. Cell 2009; 137: 60-72.
172. [172] Jeong H, Cohen DE, Cui L, et al. Sirt1 mediates neuroprotection from mutant huntingtin by activation of the TORC1 and CREB transcriptional pathway. Nat Med 2012; 18: 159-65.
173. [173] Jiang M, Wang J, Fu J, et al. Neuroprotective role of Sirt1 in mammalian models of Huntington’s disease through activation of multiple Sirt1 targets. Nat Med 2012; 18: 153-158.
174. [174] Bobrowska A, Paganetti P, Matthias P, Bates GP. Hdac6 knock-out increases tubulin acetylation but does not modify disease progression in the R6/2 mouse model of Huntington’s disease. PloS one 2011; 6: e20696.
175. [175] Chopra V, Quinti L, Kim L, et al. The Sirtuin 2 Inhibitor AK-7 Is Neuroprotectivein Huntington’s Disease Mouse Models. Cell Reports 2012; in press.
176. [176] Wijesekera L and Leigh PN. Amyotrophic lateral sclerosis. Or-phanet J Rare Dis 2009; 4.
177. [177] Han S, Choi JR, Soon SK, Kang SJ. Resveratrol upregulated heat shock proteins and extended the survival of G93A-SOD1 mice. Brain Res 2012; 1483: 112-117.
178. [178] Song W, Song Y, Kincaid B, et al. Mutant SOD1G93A triggers mitochondrial fragmentation in spinal cord motor neurons: Neuroprotection by SIRT3 and PGC-1a. Neurobiol Dis 2012; ahead of print.